DYRK1A: A promising protein kinase target for cardiomyocyte cycling and cardiac repair through epigenetic modifications.
作者信息
Bei Yihua, Wang Hongbao, Xiao Junjie
机构信息
Cardiac Regeneration and Ageing Lab, Institute of Geriatrics (Shanghai University), Affiliated Nantong Hospital of Shanghai University (The Sixth People's Hospital of Nantong), School of Medicine, Shanghai University, Nantong 226011, China; Institute of Cardiovascular Sciences, Shanghai Engineering Research Center of Organ Repair, School of Life Science, Shanghai University, Shanghai 200444, China.
Department of Cardiology, Yangpu Hospital, Tongji University School of Medicine, Shanghai 200065, China.
出版信息
EBioMedicine. 2022 Aug;82:104168. doi: 10.1016/j.ebiom.2022.104168. Epub 2022 Jul 18.
Abstract
摘要
相似文献
1
DYRK1A: A promising protein kinase target for cardiomyocyte cycling and cardiac repair through epigenetic modifications.双重特异性酪氨酸磷酸化调节激酶1A（DYRK1A）：通过表观遗传修饰促进心肌细胞周期循环和心脏修复的一种有前景的蛋白激酶靶点。
EBioMedicine. 2022 Aug;82:104168. doi: 10.1016/j.ebiom.2022.104168. Epub 2022 Jul 18.
2
Inhibition of DYRK1A, via histone modification, promotes cardiomyocyte cell cycle activation and cardiac repair after myocardial infarction.通过组蛋白修饰抑制 DYRK1A 可促进心肌梗死后心肌细胞周期激活和心脏修复。
EBioMedicine. 2022 Aug;82:104139. doi: 10.1016/j.ebiom.2022.104139. Epub 2022 Jul 8.
3
Dyrk1a regulates the cardiomyocyte cell cycle via D-cyclin-dependent Rb/E2f-signalling.Dyrk1a 通过 D 型细胞周期蛋白依赖性 Rb/E2f 信号通路调节心肌细胞周期。
Cardiovasc Res. 2016 Jun 1;110(3):381-94. doi: 10.1093/cvr/cvw074. Epub 2016 Apr 7.
4
Mechanism of dual specificity kinase activity of DYRK1A.DYRK1A 双特异性激酶活性的作用机制。
FEBS J. 2013 Sep;280(18):4495-511. doi: 10.1111/febs.12411. Epub 2013 Jul 22.
5
Involvement of the dual-specificity tyrosine phosphorylation-regulated kinase 1A-alternative splicing factor-calcium/calmodulin-dependent protein kinase IIδ signaling pathway in myocardial infarction-induced heart failure of rats.双特异性酪氨酸磷酸化调节激酶 1A-剪接因子-钙/钙调蛋白依赖性蛋白激酶 IIδ 信号通路在大鼠心肌梗死后心力衰竭中的作用。
J Card Fail. 2015 Sep;21(9):751-60. doi: 10.1016/j.cardfail.2015.05.015. Epub 2015 Jun 9.
6
Letter concerning: 'Enhanced expression of DYRK1A in cardiomyocytes inhibits acute NFAT activation but does not prevent hypertrophy in vivo'.关于“心肌细胞中DYRK1A表达增强抑制急性NFAT激活但不能预防体内肥大”的信件
Cardiovasc Res. 2011 Sep 1;91(4):742-3; author reply 743-4. doi: 10.1093/cvr/cvr192. Epub 2011 Jul 27.
7
Enhanced expression of DYRK1A in cardiomyocytes inhibits acute NFAT activation but does not prevent hypertrophy in vivo.心肌细胞中 DYRK1A 的过度表达抑制了急性 NFAT 的激活，但不能预防体内的心肌肥厚。
Cardiovasc Res. 2011 Jun 1;90(3):521-8. doi: 10.1093/cvr/cvr023. Epub 2011 Jan 27.
8
DYRK1A is a novel negative regulator of cardiomyocyte hypertrophy.双重特异性酪氨酸磷酸化调节激酶1A（DYRK1A）是心肌细胞肥大的新型负调控因子。
J Biol Chem. 2009 Jun 19;284(25):17320-17327. doi: 10.1074/jbc.M109.006759. Epub 2009 Apr 16.
9
Dual-specificity tyrosine phosphorylation-regulated kinase 1A does not require tyrosine phosphorylation for activity in vitro.双特异性酪氨酸磷酸化调节激酶1A在体外发挥活性并不需要酪氨酸磷酸化。
Biochemistry. 2007 Jun 26;46(25):7614-24. doi: 10.1021/bi700251n. Epub 2007 May 31.
10
Hyperhomocysteinemia-induced Dyrk1a downregulation results in cardiomyocyte hypertrophy in rats.高同型半胱氨酸血症诱导 Dyrk1a 下调导致大鼠心肌细胞肥大。
Int J Cardiol. 2010 Nov 19;145(2):306-307. doi: 10.1016/j.ijcard.2009.10.043. Epub 2009 Nov 10.
引用本文的文献
1
Targeting Epigenetic Regulation of Cardiomyocytes through Development for Therapeutic Cardiac Regeneration after Heart Failure.通过发育靶向心肌细胞的表观遗传调控以实现心力衰竭后治疗性心脏再生。
Int J Mol Sci. 2022 Oct 6;23(19):11878. doi: 10.3390/ijms231911878.
Zotero 插件